MLN-4760
中文名称 | MLN-4760 |
---|---|
中文同义词 | 化合物MLN-4760;((S)-1-羧基-2-(1-(3,5-二氯苄基)-1H-咪唑-5-基)乙基)-L-亮氨酸 |
英文名称 | MLN-4760 |
英文同义词 | MLN-4760;L-Histidine, N-[(1S)-1-carboxy-3-methylbutyl]-3-[(3,5-dichlorophenyl)methyl]-;((S)-1-carboxy-2-(1-(3,5-dichlorobenzyl)-1H-imidazol-5-yl)ethyl)-L-leucine;inhibit,Angiotensin-converting Enzyme (ACE),MLN 4760,Inhibitor,MLN-4760,MLN4760 |
CAS号 | 305335-31-3 |
分子式 | C19H23Cl2N3O4 |
分子量 | 428.31 |
EINECS号 | |
相关类别 | 氨基酸 |
Mol文件 | 305335-31-3.mol |
结构式 |
MLN-4760 性质
储存条件 | Store at -20°C |
---|---|
溶解度 | 可溶于DMSO |
形态 | 固体 |
Target | Value |
ACE2
(Cell-free assay) | 0.44 nM |
CPDA
(Cell-free assay) | 27 μM |
MLN-4760 is a potent and selective human ACE2 inhibitor (IC 50 , 0.44 nM), with excellent selectivity (>5000-fold) versus related enzymes human testicular ACE (IC 50 , >100 μM) and bovine carboxypeptidase A (CPDA; IC 50 , 27 μM). MLN-4760 effectively quenches cleavage of the 7-Mca-YVADAPK(Dnp) in rhACE2. MLN-4760 shows pIC 50 at rhACE2 of 8.5±0.1 and at rhACE of 4.4±0.2. MLN-4760 also shows pIC 50 at rhACE2 of 4.7±0.1, 6.9±0.1 and at ACE of 4.4±0.1, 6.2±0.1 in murine heart and mononuclear cells (MNCs), resepctively.
MLN-4760 (100 μM, intracerebroventricular infusion for five days) significantly worsens neurological function at 4 h and 3 d post-stroke without significantly increasing infarct volume.
安全信息
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024/04/30 | HY-19414 | MLN-4760 MLN-4760 | 305335-31-3 | 1mg | 1550元 |
2024/04/30 | HY-19414 | MLN-4760 MLN-4760 | 305335-31-3 | 5mg | 3150元 |